What you pay for an ApoB test depends on how it is ordered, not on the marker itself. A single add-on test, a bundled cardiovascular panel and a hospital draw are priced differently. FitScript includes ApoB in its Heart Health panel, and the current price is shown with the panel details on this page.
The assay itself is routine. ApoB is measured by immunoassay on the same tube of blood a lipid panel uses, so the number on your invoice reflects packaging, access and who is doing the ordering far more than laboratory difficulty. The Heart Health panel is HSA/FSA eligible, which changes how the payment is made rather than what the test costs.
Apolipoprotein B is the structural protein wrapped around every atherogenic lipoprotein particle, at one molecule per particle, so measuring it in blood produces a count of those particles rather than an estimate of the cholesterol inside them. That is the whole idea behind Apolipoprotein B as a lipid marker, and reviews have described it as the common denominator that ties the different lipoprotein measurements together 1.
The result is reported as a concentration in mg/dL. Here is how it sits alongside the numbers you already get on a standard panel.
| Marker | Unit | What the number reports |
|---|---|---|
| ApoB | mg/dL | The number of atherogenic lipoprotein particles in circulation |
| LDL cholesterol | mg/dL | The mass of cholesterol carried inside LDL particles, often calculated rather than measured |
| Non-HDL cholesterol | mg/dL | Cholesterol carried in all atherogenic particles, total cholesterol minus HDL-C |
| Triglycerides | mg/dL | Fat carried within lipoproteins, sensitive to recent meals |
Reference ranges for ApoB are typical lab reference ranges and vary by lab, age and sex. Your report lists the interval the performing lab used, and that interval describes how a population distributes, not a personal target.
It adds a particle count to a panel that otherwise reports cholesterol mass, and the two can disagree in the same person. Each atherogenic particle carries exactly one ApoB molecule regardless of how much cholesterol it happens to be hauling, which is why the measurement behaves as a count 1.
That matters when cholesterol mass and particle number separate. Research suggests that, where the two markers disagree, the particle count tracks cardiovascular risk more closely, a pattern attributed to physiological differences in how cholesterol is distributed across particles of varying size 2. A 2025 comparison of ApoB, LDL-C and non-HDL-C as risk markers suggests the three overlap heavily for most people and separate in a minority, which is the group an ApoB measurement is most useful for identifying 3.
An expert clinical consensus from the National Lipid Association has addressed how ApoB fits into the clinical management of cardiovascular risk in adults 4, and a 2024 review in Circulation framed the current situation as a gap between the strength of the evidence and how often the test is actually ordered 5. Reviews of apolipoprotein B describe discordance between LDL cholesterol and particle number as most relevant when triglycerides are elevated or metabolic health is impaired, because cholesterol-depleted particles can leave LDL-C looking reassuring while the particle count stays high 6. Beyond coronary risk, higher ApoB is associated with later ischemic stroke in prospective observation 7.
None of this makes ApoB a replacement for the rest of the panel. It is one more axis on the same blood draw.
The same assay can carry very different prices depending on how it reaches you. These are the variables that move the number, in rough order of how much they tend to matter.
| Factor | Why it moves the price |
|---|---|
| Standalone test or bundled panel | Single add-on tests carry the full overhead of an order and a draw. Bundling spreads that across many markers |
| Where blood is drawn | Hospital outpatient departments, independent draw sites and mobile phlebotomy each have different cost structures |
| Who orders it | A test ordered inside a clinical visit is priced differently from one ordered through a direct-to-consumer or membership pathway |
| Billing route | A cash or membership price and a price billed through a health plan are two different numbers for the same work |
| Whether interpretation is included | Some prices cover only the result. Others include clinician or structured interpretation |
| Volume and contracting | Labs quote different rates to different buyers, and those contracted rates are not public |
| Retesting cadence | A marker you follow over time is a recurring cost, not a one-off |
Two of these catch people out. The first is the difference between a list price and a negotiated rate, which means a posted figure may bear little relation to what anyone actually pays. The second is the draw setting, because the venipuncture and specimen handling can account for a meaningful share of the total on a single-marker order while barely registering on a large panel.
This is why asking what an ApoB test costs in the abstract rarely produces a useful answer. The practical question is what a specific panel from a specific provider costs, with the draw and the result delivery included.
Coverage varies by plan and by why the test is ordered, so the only reliable step is to check with your plan before the draw. In general, whether a lipid-related test is covered tends to depend on the clinical reason recorded with the order, the plan's own rules, and whether the lab is in network. A test ordered for optimization or screening outside a documented clinical indication is often handled differently from one ordered during workup of a known problem.
Testing bought outside insurance is usually priced as a flat amount you can see before you commit, which some people prefer precisely because there is no later bill to interpret. The Heart Health panel is HSA/FSA eligible, so those funds can be used toward it.
ApoB is included in the Heart Health panel rather than sold as a single marker, which is the usual way it is ordered because the number is most interpretable next to the rest of the lipid picture. Panels built around cardiovascular risk typically group ApoB with a full lipid panel, markers of inflammation and related metabolic measures, and the complete marker list for this panel is shown with the panel details on this page, along with the current price.
The membership sits around the testing rather than beside it. Members have 150+ biomarkers tested per year, and results are interpreted by Atlas, FitScript's AI health advisor, which reads the panel as a set rather than one line at a time. Where a result suggests treatment might be worth considering, a licensed provider evaluates whether anything is appropriate for that individual. No medication or therapy is decided by a test result alone.
If you want the particle count read in context, ordering it inside a cardiovascular panel is both cheaper per marker and more useful than chasing ApoB on its own.
Follow whatever preparation instructions come with your specific order, because they are set by the lab running the assay. ApoB is generally less sensitive to a recent meal than triglycerides are, but the instruction attached to your panel is the one that governs.
Beyond that, the useful principle is consistency. Lipid markers drift with ordinary life, so comparing two results is easier when the conditions match. Try to draw at a similar time of day, keep the days before the test typical rather than unusually disciplined or unusually heavy, avoid an uncharacteristic alcohol night or a punishing training session immediately beforehand, and drink water so the draw itself goes smoothly. Keep a note of medications and supplements you are taking, since several affect lipid results and a clinician reading the panel needs to know.
Acute illness, recent infection and very recent major weight change can all shift lipid numbers temporarily. If any of those apply, it is reasonable to ask whether to wait before testing.
Start with the observation. Your report gives an ApoB concentration in mg/dL next to the reference interval the lab used. A value above that interval means your measured particle count sits above the population range the lab defines, nothing more specific than that on its own.
Then the meaning, carefully. A single suboptimal ApoB is a data point, not a diagnosis, and interpretation depends on the rest of the panel, your history and your overall risk picture. The reverse case matters too, since an LDL cholesterol inside range alongside a higher ApoB is the discordance pattern that makes the extra marker worth measuring 3.
Then the next step. Bring the result to a clinician or licensed provider, who can place it against your full history and decide what, if anything, should change. Never ignore a result that sits outside the standard range, and if a value is flagged as needing attention, it is worth discussing with a clinician promptly. On the lifestyle side, a meta-analysis of randomized trials found that psyllium fiber may help lower ApoB alongside LDL cholesterol and non-HDL cholesterol 8, and a separate meta-analysis of randomized controlled trials suggests oat beta-glucan has a similar direction of effect on these markers 9. Any decision about medication belongs to a licensed provider who has evaluated you.
This page is educational and is not medical advice.
Related reading on this site covers the discordance question in more depth in can you have high ldl and low apob, and the marker list and current price for the Heart Health panel are shown with the panel details.
Because there is no single price. The same assay is priced differently depending on the panel it sits in, the draw setting, the billing route and the lab's contracted rate. For this panel, the current price is shown with the panel details on this page.
The Heart Health panel, which includes ApoB, is marked HSA/FSA eligible, so those funds can be used toward it. Eligibility rules for your specific account are set by your administrator, so confirm with them if you are unsure how to apply the funds.
Coverage varies by plan and by why the test is ordered, so check with your plan before the draw. Whether a lipid-related test is covered usually depends on the clinical reason recorded with the order, your plan's own rules and whether the lab is in network.
No. LDL cholesterol reports the mass of cholesterol inside LDL particles and is often calculated rather than measured. ApoB counts the atherogenic particles themselves, since each carries one ApoB molecule. The two usually agree, and the useful information appears when they do not.
No, it sits alongside one. ApoB is most interpretable next to total cholesterol, LDL-C, HDL-C and triglycerides, which is why it is normally ordered inside a cardiovascular panel rather than as a single marker. Ordering it bundled is also cheaper per marker.
Follow the preparation instructions supplied with your specific order, since they are set by the lab running the assay. ApoB is generally less sensitive to a recent meal than triglycerides are, but the instruction attached to your panel is the one that applies.
It depends on the pathway. Tests ordered inside a clinical visit go through your clinician. Membership and direct-to-consumer pathways handle the order differently. Either way, bring the result to a clinician or licensed provider, who decides what it means for you.
Retesting cadence is a clinical decision rather than a fixed schedule, and it depends on your baseline, your history and whether anything has changed. Because it is recurring, cadence is also a real part of the long-term cost. Discuss timing with your clinician.
Treat it as one data point, not a diagnosis. A value above the reference interval is suboptimal relative to that lab's population range and needs to be read against your full panel and history. Discuss it with a clinician, and do not ignore a flagged result.